Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 13Active not recruiting 5Terminated 4Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2Breast 2Tumor-Agnostic 1Head & Neck 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Breast Neoplasms 2Osteoporotic Fractures 1Osteoporosis 1Osteopetrosis, mild autosomal recessive form 1Osteopetrosis, Autosomal Recessive 7 1Musculoskeletal Pain 1Arthralgia 1

Interventions

Cyclophosphamide 89Capecitabine 88Trastuzumab 81Docetaxel 81Paclitaxel 65Epirubicin 57pyrotinib 55Tamoxifen 54Letrozole 53Fulvestrant 49Vinorelbine 43Carboplatin 43Doxorubicin 41Radiotherapy 33Anastrozole 32exemestane 31Neoadjuvant Therapy 29palbociclib 27Drug Therapy 27Fluorouracil 24Bevacizumab 24pertuzumab 23Cisplatin 23eribulin 22Exercise 21130-nm albumin-bound paclitaxel 21Goserelin 20Gemcitabine 20Chemotherapy, Adjuvant 19Albumin-Bound Paclitaxel 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Denosumab × Breast × Clear all
NCT03691311 2021-11-03

D-BIOMARK

Institut Català d'Oncologia

Phase EARLY_PHASE1 Unknown
60 enrolled
Breast

Osteopetrosis, mild autosomal recessive form, Osteopetrosis, Autosomal Recessive 7, Breast Neoplasms

NCT03811509 2019-01-28

B-ABLE

Parc de Salut Mar

Phase 4 Unknown
1,000 enrolled
Breast

Breast Neoplasms, Osteoporosis, Arthralgia, Osteoporotic Fractures, Musculoskeletal Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡